We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 203 results
  1. Understanding adefovir pharmacokinetics as a component of a transporter phenoty** cocktail

    Purpose

    Adefovir (as dipivoxil) was selected as a probe drug in a previous transporter cocktail phenoty** study to assess renal organic anion...

    Qian Dong, Chunli Chen, ... Charalambos Dokos in European Journal of Clinical Pharmacology
    Article Open access 28 March 2024
  2. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals

    Purpose

    This study aimed to improve the in vitro dissolution, permeability and oral bioavailability of adefovir dipivoxil (ADD) by cocrystal...

    Luyuan Li, Zunting Pang, ... Shuai Qian in Pharmaceutical Research
    Article 01 October 2021
  3. Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator

    Purpose

    Adefovir dipivoxil (AD), a nucleoside reverse transcriptase inhibitor is effective against Hepatitis B virus. Its poor oral bioavailability...

    Shady M. Abd El-Halim, Ghada A. Abdelbary, ... Ahmed B. Ibrahim in DARU Journal of Pharmaceutical Sciences
    Article 20 June 2020
  4. Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

    Background

    Progressive bone pain and fracture and abnormal positron emission tomography combined with a computed tomography are main reasons for the...

    Qian **ang, Zhiyan Liu, ... Yimin Cui in BMC Pharmacology and Toxicology
    Article Open access 05 June 2020
  5. Role of plasmatic and urinary concentration of tenofovir disoproxil fumarate in a cohort of patients affected by chronic hepatitis B

    The aim of this study was to evaluate plasmatic and urinary therapeutic drug monitoring (TDM) of tenofovir disoproxil fumarate (TDF) in a cohort of...

    Lucio Boglione, Ilaria De Benedetto, ... Antonio D’Avolio in Archives of Virology
    Article 22 May 2022
  6. Mitigating Drug Stability Challenges Through Cocrystallization

    Drug stability plays a significant role in the pharmaceutical industry from early-phase drug discovery to product registration as well as the entire...

    Jamshed Haneef, Mohd Amir, ... Renu Chadha in AAPS PharmSciTech
    Article 09 February 2023
  7. Cross-sectional retrospective analysis of clinical characteristics of chronic hepatitis B patients with oral antiviral treatment in eastern China

    Background

    In China, more than 20 million patients with chronic hepatitis B need antiviral treatment. Side effects of antiviral treatment such as...

    Jueqing Gu, Guodong Yu, ... Weiti Wu in Virology Journal
    Article Open access 13 January 2021
  8. Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4

    Purpose

    To study the correlations of genetic variants of telbivudine phosphorylase kinases and telbivudine plasma concentration with creatine kinase...

    Tianye He, Bicui Chen, ... Jianfei Long in European Journal of Clinical Pharmacology
    Article 19 March 2024
  9. Phosphoryl prodrugs: characteristics to improve drug development

    Phosphoryl prodrugs are key compounds in drug development. Biologically active phosphoryl compounds often have negative charges on the phosphoryl...

    Samuel A. Kirby, Cynthia S. Dowd in Medicinal Chemistry Research
    Article 23 July 2021
  10. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series

    Background

    Adefovir dipivoxil (ADV)-induced renal tubular dysfunction and hypophosphatemic osteomalacia (HO) have been given great consideration in...

    Nan Chen, Jian-bo Zhang, ... Kuan-xiao Tang in BMC Pharmacology and Toxicology
    Article Open access 16 May 2018
  11. Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives

    The present work reviews the liquid antisolvent crystallization (LASC) to prepare the nanoparticle of pharmaceutical compounds to enhance their...

    Rahul Kumar, Amit K. Thakur, ... Raj Kumar Arya in Drug Delivery and Translational Research
    Article 11 August 2022
  12. Antivirals: Approaches and the Way Forward

    Viral diseases pose significant challenges in human and veterinary medicine, as effective treatment options are limited. The development of antiviral...
    Adarsh Mishra, Inderpal Kaur, ... Yashpal Singh Malik in Advances in Antiviral Research
    Chapter 2024
  13. Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya

    Background

    Hepatitis B virus (HBV) causes significant morbidity and mortality globally primarily due to its ability to cause hepatitis, liver...

    Patrick Okoti Aluora, Margaret Wangui Muturi, George Gachara in Virology Journal
    Article Open access 13 November 2020
  14. The antiviral potential of Phyllanthus species: a systematic review

    Viral infections and diseases caused by viruses are worldwide problems. According to a WHO report, three to five million people are chronically...

    Richa Upadhyay, Kavindra Nath Tiwari in Archives of Virology
    Article 13 June 2023
  15. Synergistic Herb-Drug Interactions Against Viral Diseases

    Emerging or reemerging viruses are of serious concern as they are associated with higher degree of mortality and deleterious impact on human life....
    Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble in Herb-Drug Combinations
    Chapter 2022
  16. Antiviral Drugs

    Viruses are obligate intracellular organisms. They require host cell for replication process. Different classes of drugs are available for targeting...
    Chapter 2021
  17. Cocrystallization and Coamorphization for Druggability Enhancement of Chinese Medicines

    Cocrystallization and coamorphization techniques incorporating active ingredient of Chinese medicine and an or more appropriate coformer(s) into a...
    Hao Cheng, Weili Heng, ... Yuan Gao in Novel Drug Delivery Systems for Chinese Medicines
    Chapter 2021
  18. Genotype and Phenotype of Renal Hypouricemia: A Single-Center Study from China

    Background

    Renal hypouricemia (RHUC), a rare inherited disorder characterized by impaired uric acid reabsorption and subsequent profound hypouricemia,...

    Lijun Mou, Lina Zhu, ... Ying Xu in Molecular Diagnosis & Therapy
    Article 16 November 2023
  19. Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma

    Background and aim

    Although antiviral treatments have been shown to affect the recurrence and long-term survival of patients with hepatocellular...

    Peng Wang, **nhui Wang, ... Zhiyun Yang in BMC Cancer
    Article Open access 20 June 2023
  20. Nanomedicines to Improve Oral Delivery of Antiretroviral Drugs

    Over the years, oral drug delivery has been the route of choice for drug administration, and with no exception, the marketed antiretroviral...
    Chapter 2023
Did you find what you were looking for? Share feedback.